{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T07:58:39Z","timestamp":1793692719328,"version":"4.5.1"},"reference-count":50,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"15","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":["J Am Acad Orthop Surg","JAAOS"],"published-print":{"date-parts":[[2025,8,1]]},"abstract":"<jats:sec>\n                    <jats:title>Introduction:<\/jats:title>\n                    <jats:p>Diabetes mellitus (DM) is a common comorbidity in total knee arthroplasty (TKA) patients, which has been associated with multiple complications. Sodium-glucose cotransporter 2 inhibitors (SGLT2i) are one class of medications recently approved to better manage DM. This study investigates the correlation of SGLT2i use on postoperative complications and revision rates for diabetic patients undergoing TKA.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>The M157 PearlDiver database was used to identify DM patients undergoing primary TKA. Those prescribed SGLT2i were identified and matched in 1:4 ratio with control DM patients based on age, sex, obesity diagnosis, and Elixhauser comorbidity index. Ninety-day adverse events and 5-year rates of revision were abstracted and compared by multivariable regression, controlling for age, sex, Elixhauser comorbidity index, long-term insulin use, obesity, metformin use, and active tobacco use.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>\n                      A total of 164,474 TKA patients with DM were identified, of which SGLT2i were prescribed for 9,246 (5.6%). On multivariable analysis, SGLT2i use in DM patients was independently associated with higher odds of aggregated adverse events driven by myocardial infarction (odds ratio [OR] 2.40), sepsis (OR 1.81), urinary tract infection (OR 2.10), pneumonia (OR 1.87), and acute kidney injury (OR 1.33) but had lower odds of transfusion (OR 0.31) (\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      &lt; 0.0001 for each). On multivariable analysis, 5-year survival to revision TKA were not markedly different between the matched cohorts.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Discussion:<\/jats:title>\n                    <jats:p>SGLT2i are being increasingly prescribed for DM patients undergoing TKA. Although they are associated with increased risk of multiple 90-day perioperative adverse outcomes, they are also associated with reduced incidence of blood transfusion. These results may guide surgical decision making and counseling for patients taking this group of medications and align with some prior studies related to glucagon-like protein-1 agonists.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.5435\/jaaos-d-24-00299","type":"journal-article","created":{"date-parts":[[2024,12,4]],"date-time":"2024-12-04T15:00:18Z","timestamp":1733324418000},"page":"856-862","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":7,"title":["Patients With Diabetes on Sodium-Glucose Cotransporter-2 Inhibitors Undergoing Total Knee Arthroplasty Are at Increased Odds for a Number of Postoperative Adverse Events But Reduced Risk of Transfusion"],"prefix":"10.5435","volume":"33","author":[{"given":"Lucas Y.","family":"Kim","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel H.","family":"Wiznia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2626-7278","authenticated-orcid":false,"given":"Jonathan N.","family":"Grauer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2024,11,26]]},"reference":[{"key":"R2-20250718","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1089\/pop.2015.0181","article-title":"Diabetes 2030: Insights from yesterday, today, and future trends","volume":"20","author":"Rowley","year":"2017","journal-title":"Popul Health Manag"},{"key":"R3-20250718","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/s12963-018-0166-4","article-title":"Projection of the future diabetes burden in the United States through 2060","volume":"16","author":"Lin","year":"2018","journal-title":"Popul Health Metr"},{"key":"R4-20250718","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.cger.2014.08.019","article-title":"Links between osteoarthritis and diabetes:implications for management from a physical activity perspective","volume":"31","author":"Piva","year":"2015","journal-title":"Clin Geriatr Med"},{"key":"R5-20250718","doi-asserted-by":"crossref","first-page":"e10","DOI":"10.2106\/JBJS.RVW.17.00146","article-title":"Diabetes and hyperglycemia in lower-extremity total joint arthroplasty: Clinical epidemiology, outcomes, and management","volume":"6","author":"Rudy","year":"2018","journal-title":"JBJS Rev"},{"key":"R6-20250718","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1186\/s13018-023-03982-4","article-title":"Does diabetes mellitus impair the clinical results of total knee arthroplasty under enhanced recovery after surgery?","volume":"18","author":"Li","year":"2023","journal-title":"J Orthop Surg Res"},{"key":"R7-20250718","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1016\/j.arth.2023.09.019","article-title":"Risk factors associated with postoperative cardiac events following total hip and knee arthroplasty","volume":"39","author":"Chokshi","year":"2024","journal-title":"J Arthroplasty"},{"issue":"6 suppl","key":"R8-20250718","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.arth.2008.05.012","article-title":"The impact of diabetes on perioperative patient outcomes after total hip and total knee arthroplasty in the United States","volume":"23","author":"Bolognesi","year":"2008","journal-title":"J Arthroplasty"},{"key":"R9-20250718","doi-asserted-by":"crossref","first-page":"601","DOI":"10.2106\/JBJS.20.01535","article-title":"Metformin use is associated with fewer complications in patients with type-2 diabetes undergoing total knee arthroplasty: A propensity score-matched analysis","volume":"103","author":"Wilson","year":"2021","journal-title":"J Bone Joint Surg Am"},{"key":"R10-20250718","doi-asserted-by":"crossref","first-page":"2311","DOI":"10.1016\/j.arth.2023.05.071","article-title":"Does semaglutide use decrease complications and costs following total knee arthroplasty?","volume":"38","author":"Magruder","year":"2023","journal-title":"J Arthroplasty"},{"key":"R11-20250718","first-page":"100725","article-title":"Systematic review and meta-analysis: SGLT2 inhibitors, blood pressure and cardiovascular outcomes","volume":"33","author":"Benham","year":"2021","journal-title":"Int J Cardiol Heart Vasc"},{"key":"R12-20250718","first-page":"e26313","article-title":"A systematic review of sodium-glucose cotransporter 2 (SGLT2) inhibitors and sympathetic nervous system inhibition: An underrated mechanism of cardiorenal protection","volume":"14","author":"Raza","year":"2022","journal-title":"Cureus"},{"key":"R13-20250718","doi-asserted-by":"crossref","first-page":"161","DOI":"10.2147\/DMSO.S233538","article-title":"Extraglycemic effects of SGLT2 inhibitors: A review of the evidence","volume":"13","author":"Bonora","year":"2020","journal-title":"Diabetes Metab Syndr Obes"},{"key":"R14-20250718","doi-asserted-by":"crossref","first-page":"4","DOI":"10.2337\/diaclin.32.1.4","article-title":"SGLT-2 inhibitors: A new mechanism for glycemic control","volume":"32","author":"Chao","year":"2014","journal-title":"Clin Diabetes"},{"key":"R15-20250718","doi-asserted-by":"crossref","first-page":"630820","DOI":"10.3389\/fphar.2021.630820","article-title":"Effects of sodium-glucose co-transporter 2 inhibitors on hemoglobin levels: A meta-analysis of randomized controlled trials","volume":"12","author":"Qu","year":"2021","journal-title":"Front Pharmacol"},{"key":"R16-20250718","doi-asserted-by":"crossref","first-page":"S275","DOI":"10.1016\/j.arth.2023.10.052","article-title":"Total hip arthroplasty in patients who have Marfan syndrome: Adverse events and 5-year revision rates","volume":"39","author":"Day","year":"2024","journal-title":"J Arthroplasty"},{"key":"R17-20250718","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1016\/j.arth.2022.12.012","article-title":"Total hip arthroplasty imageless navigation does not reduce 90-day adverse events or five-year revisions in a large national cohort","volume":"38","author":"Jayaram","year":"2023","journal-title":"J Arthroplasty"},{"key":"R18-20250718","doi-asserted-by":"crossref","first-page":"2259","DOI":"10.1016\/j.arth.2023.05.072","article-title":"Total knee arthroplasty: Variables affecting 90-day overall reimbursement","volume":"38","author":"Halperin","year":"2023","journal-title":"J Arthroplasty"},{"key":"R19-20250718","first-page":"e22.00262","article-title":"Magnetic resonance imaging in the year prior to total knee arthroplasty: A potential overutilization of healthcare resources","volume":"7","author":"Rudisill","year":"2023","journal-title":"J Am Acad Orthop Surg Glob Res Rev"},{"key":"R20-20250718","doi-asserted-by":"crossref","first-page":"1822","DOI":"10.1016\/j.arth.2022.04.016","article-title":"Outcomes following total hip arthroplasty in patients with postpolio syndrome: A matched cohort analysis","volume":"37","author":"Mercier","year":"2022","journal-title":"J Arthroplasty"},{"key":"R21-20250718","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1097\/00005650-199801000-00004","article-title":"Comorbidity measures for use with administrative data","volume":"36","author":"Elixhauser","year":"1998","journal-title":"Med Care"},{"key":"R22-20250718","first-page":"e23.00108","article-title":"Patients with down syndrome and total hip and total knee arthroplasty: Outcome measures show increased risk of perioperative complications","volume":"7","author":"Halperin","year":"2023","journal-title":"J Am Acad Orthop Surg Glob Res Rev"},{"key":"R23-20250718","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1177\/10711007231189698","article-title":"Adverse events after ankle fracture open reduction internal fixation among patients with and without documented cannabis and tobacco use","volume":"44","author":"Dhodapkar","year":"2023","journal-title":"Foot Ankle Int"},{"key":"R24-20250718","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1097\/BRS.0000000000004580","article-title":"Anterior cervical discectomy and fusion outcomes in patients with and without bariatric surgery-weight loss does make a difference","volume":"48","author":"Joo","year":"2023","journal-title":"Spine"},{"key":"R26-20250718","doi-asserted-by":"crossref","first-page":"108204","DOI":"10.1016\/j.jdiacomp.2022.108204","article-title":"Prevalence of SGLT2i and GLP1RA use among US adults with type 2 diabetes","volume":"36","author":"Limonte","year":"2022","journal-title":"J Diabetes Complications"},{"key":"R29-20250718","first-page":"e21720","article-title":"Frequency of urinary tract infections in type 2 diabetic patients taking dapagliflozin","volume":"14","author":"Khan","year":"2022","journal-title":"Cureus"},{"key":"R30-20250718","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1590\/1806-9282.65.2.246","article-title":"Use of sodium-glucose cotransporter-2 inhibitors and urinary tract infections in type 2 diabetes patients: A systematic review","volume":"65","author":"Figueiredo","year":"2019","journal-title":"Rev Assoc Med Bras (1992)"},{"key":"R31-20250718","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1111\/dom.12825","article-title":"Urinary tract and genital infections in patients with type 2 diabetes treated with sodium-glucose co-transporter 2 inhibitors: A meta-analysis of randomized controlled trials","volume":"19","author":"Li","year":"2017","journal-title":"Diabetes Obes Metab"},{"key":"R32-20250718","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1093\/ckj\/sfz170","article-title":"The risk for urinary tract infections with sodium-glucose cotransporter 2 inhibitors: No longer a cause of concern?","volume":"13","author":"Sarafidis","year":"2020","journal-title":"Clin Kidney J"},{"key":"R33-20250718","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1038\/s41574-019-0275-6","article-title":"SGLT2 inhibitors and urinary tract infections","volume":"15","author":"Wilding","year":"2019","journal-title":"Nat Rev Endocrinol"},{"key":"R34-20250718","doi-asserted-by":"crossref","first-page":"101367","DOI":"10.1016\/j.diabet.2022.101367","article-title":"Risk of sepsis and pneumonia in patients initiated on SGLT2 inhibitors and DPP-4 inhibitors","volume":"48","author":"Wu","year":"2022","journal-title":"Diabetes Metab"},{"key":"R35-20250718","doi-asserted-by":"crossref","first-page":"e1719","DOI":"10.1210\/clinem\/dgab818","article-title":"Association between SGLT2 inhibitors vs DPP-4 inhibitors and risk of pneumonia among patients with type 2 diabetes","volume":"107","author":"Au","year":"2022","journal-title":"J Clin Endocrinol Metab"},{"key":"R36-20250718","doi-asserted-by":"crossref","first-page":"3442","DOI":"10.1210\/clinem\/dgac558","article-title":"Sodium-glucose cotransporter 2 inhibitors and the risk of pneumonia and septic shock","volume":"107","author":"Li","year":"2022","journal-title":"J Clin Endocrinol Metab"},{"key":"R37-20250718","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1186\/s12916-023-02765-2","article-title":"Association of adverse respiratory events with sodium-glucose cotransporter 2 inhibitors versus dipeptidyl peptidase 4 inhibitors among patients with type 2 diabetes in South Korea: A nationwide cohort study","volume":"21","author":"Jeong","year":"2023","journal-title":"BMC Med"},{"key":"R38-20250718","doi-asserted-by":"crossref","first-page":"15922","DOI":"10.1038\/s41598-023-42989-z","article-title":"SGLT-2 inhibitors improve cardiovascular and renal outcomes in patients with CKD: A systematic review and meta-analysis","volume":"13","author":"Mavrakanas","year":"2023","journal-title":"Sci Rep"},{"key":"R39-20250718","doi-asserted-by":"crossref","first-page":"e030578","DOI":"10.1161\/JAHA.123.030578","article-title":"Sodium-glucose cotransporter-2 inhibitors and primary prevention of atherosclerotic cardiovascular disease: A meta-analysis of randomized trials and systematic review","volume":"12","author":"Rahman","year":"2023","journal-title":"J Am Heart Assoc"},{"key":"R40-20250718","first-page":"7620","article-title":"Effect of sodium-glucose co-transporter-2 inhibitors on coronary blood flow in patients with type 2 diabetes mellitus","volume":"27","author":"Ta\u015ftan","year":"2023","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"R41-20250718","doi-asserted-by":"crossref","first-page":"2058","DOI":"10.1016\/j.jacc.2022.03.353","article-title":"Sodium glucose cotransporter-2 inhibition for acute myocardial infarction: JACC review topic of the week","volume":"79","author":"Udell","year":"2022","journal-title":"J Am Coll Cardiol"},{"key":"R42-20250718","doi-asserted-by":"crossref","first-page":"6202","DOI":"10.3390\/jcm12196202","article-title":"Role of sodium-glucose co-transporter 2 inhibitors in chronic kidney disease, congestive heart failure and stroke\u2014A review and clinical guide for healthcare professionals","volume":"12","author":"Singh","year":"2023","journal-title":"J Clin Med"},{"key":"R43-20250718","doi-asserted-by":"crossref","first-page":"8244047","DOI":"10.1155\/2022\/8244047","article-title":"Predicting postoperative troponin in patients undergoing elective hip or knee arthroplasty: A comparison of five cardiac risk prediction tools","volume":"2022","author":"Tesfazghi","year":"2022","journal-title":"Cardiol Res Pract"},{"key":"R44-20250718","doi-asserted-by":"crossref","first-page":"e287","DOI":"10.1161\/CIR.0000000000001024","article-title":"Diagnosis and management of patients with myocardial injury after noncardiac surgery: A scientific statement from the American Heart Association","volume":"144","author":"Ruetzler","year":"2021","journal-title":"Circulation"},{"key":"R45-20250718","doi-asserted-by":"crossref","first-page":"e004040","DOI":"10.1161\/CIRCOUTCOMES.117.004040","article-title":"Myocardial injury in patients with sepsis and its association with long-term outcome","volume":"11","author":"Frencken","year":"2018","journal-title":"Circ Cardiovasc Qual Outcomes"},{"key":"R46-20250718","doi-asserted-by":"crossref","first-page":"e002496","DOI":"10.1136\/bmjdrc-2021-002496","article-title":"Renal effectiveness and safety of the sodium-glucose cotransporter-2 inhibitors: A population-based cohort study","volume":"9","author":"Alkabbani","year":"2021","journal-title":"BMJ Open Diabetes Res Care"},{"key":"R47-20250718","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1053\/j.ajkd.2020.03.019","article-title":"Acute kidney injury events in patients with type 2 diabetes using SGLT2 inhibitors versus other glucose-lowering drugs: A retrospective cohort study","volume":"76","author":"Rampersad","year":"2020","journal-title":"Am J Kidney Dis"},{"key":"R48-20250718","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1111\/dom.13532","article-title":"Acute renal outcomes with sodium-glucose co-transporter-2 inhibitors: Real-world data analysis","volume":"21","author":"Cahn","year":"2019","journal-title":"Diabetes Obes Metab"},{"key":"R49-20250718","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1007\/s40620-022-01422-w","article-title":"Is there any robust evidence showing that SGLT2 inhibitor use predisposes to acute kidney injury?","volume":"36","author":"Copur","year":"2023","journal-title":"J Nephrol"},{"key":"R50-20250718","doi-asserted-by":"crossref","first-page":"3223","DOI":"10.1002\/ehf2.14489","article-title":"Short-term outcomes after sodium-glucose cotransporter-2 inhibitor initiation in a cohort of heart failure patients","volume":"10","author":"P\u00e9rez Mart\u00ednez","year":"2023","journal-title":"ESC Heart Fail"},{"key":"R51-20250718","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1038\/nrneph.2016.159","article-title":"Acute kidney injury from SGLT2 inhibitors: Potential mechanisms","volume":"12","author":"Hahn","year":"2016","journal-title":"Nat Rev Nephrol"},{"key":"R52-20250718","doi-asserted-by":"crossref","first-page":"263","DOI":"10.3949\/ccjm.86a.18044","article-title":"Acute kidney injury after hip or knee replacement: Can we lower the risk?","volume":"86","author":"Filippone","year":"2019","journal-title":"Cleve Clin J Med"},{"key":"R53-20250718","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1007\/s11255-021-02943-2","article-title":"Effect of sodium-glucose cotransporter 2 inhibitors on hemoglobin and hematocrit levels in type 2 diabetes: A systematic review and meta-analysis","volume":"54","author":"Kanbay","year":"2022","journal-title":"Int Urol Nephrol"},{"key":"R54-20250718","first-page":"69","article-title":"Risk factors for post-operative blood transfusion following total knee arthroplasty","volume":"40","author":"Owens","year":"2020","journal-title":"Iowa Orthop J"}],"container-title":["Journal of the American Academy of Orthopaedic Surgeons"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.5435\/JAAOS-D-24-00299","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T14:50:27Z","timestamp":1787669427000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.5435\/JAAOS-D-24-00299"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11,26]]},"references-count":50,"journal-issue":{"issue":"15","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.5435\/jaaos-d-24-00299","relation":{},"ISSN":["1067-151X","1940-5480"],"issn-type":[{"value":"1067-151X","type":"print"},{"value":"1940-5480","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,11,26]]},"assertion":[{"value":"2024-03-14","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-04-26","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}